Skip to main content
Fig. 8 | BMC Pulmonary Medicine

Fig. 8

From: A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

Fig. 8

Network evidence map of FVC (% predicted)absolute change from baseline. A total of 9 studies reported the FVC (% predicted) absolute change from baseline in patients with IPF treated with 7 drugs: 1 of Ambrisentan, 1 of Nintedanib, 1 of Pamrevlumab, 2 of Pirfenidone, 1 of PRM-151, 2 of Sildenafil, 1 of Warfarin

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us